Notis-McConarty Edward’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,307
Closed -$983K 79
2024
Q4
$983K Sell
12,307
-9,038
-42% -$782K 0.48% 45
2024
Q3
$1.92M Sell
21,345
-3,845
-15% -$323K 0.87% 34
2024
Q2
$1.98M Sell
25,190
-215
-0.8% -$17.6K 0.78% 36
2024
Q1
$2.21M Sell
25,405
-1,281
-5% -$109K 0.88% 35
2023
Q4
$2.2M Buy
26,686
+260
+1% +$19.8K 0.88% 32
2023
Q3
$2.07M Buy
26,426
+500
+2% +$41.9K 0.84% 35
2023
Q2
$2.28M Buy
25,926
+3,452
+15% +$297K 0.87% 35
2023
Q1
$1.81M Buy
22,474
+10,263
+84% +$836K 0.72% 40
2022
Q4
$949K Sell
12,211
-10,343
-46% -$838K 0.4% 56
2022
Q3
$1.82M Buy
22,554
+2,222
+11% +$200K 0.81% 37
2022
Q2
$1.82M Buy
20,332
+11,397
+128% +$1.15M 0.76% 39
2022
Q1
$991K Buy
+8,935
New +$944K 0.35% 63

Other funds holding MDT

Notis-McConarty Edward's MDT Position: Q1 2025 in Review

Notis-McConarty Edward sold out of Medtronic (MDT) in Q1 2025, closing a stake of 12,307 shares — an estimated $983K sold.

Notis-McConarty Edward first reported a position in MDT in Q1 2022 and held it in 12 quarters. The position peaked at $2.28M in Q2 2023. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Notis-McConarty Edward reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Notis-McConarty Edward sold 12,307 Medtronic shares in Q1 2025, an estimated $983K.
  • Notis-McConarty Edward first reported a position in Medtronic in Q1 2022 and held it in 12 quarters.
  • Notis-McConarty Edward's Medtronic position peaked at $2.28M in Q2 2023.
  • 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Notis-McConarty Edward's 13F filing for Q1 2025, filed 6 May 2025.